全文获取类型
收费全文 | 65519篇 |
免费 | 5410篇 |
国内免费 | 1283篇 |
专业分类
耳鼻咽喉 | 217篇 |
儿科学 | 851篇 |
妇产科学 | 564篇 |
基础医学 | 4727篇 |
口腔科学 | 975篇 |
临床医学 | 6156篇 |
内科学 | 9606篇 |
皮肤病学 | 352篇 |
神经病学 | 3943篇 |
特种医学 | 1442篇 |
外国民族医学 | 2篇 |
外科学 | 3704篇 |
综合类 | 7422篇 |
现状与发展 | 5篇 |
一般理论 | 5篇 |
预防医学 | 11401篇 |
眼科学 | 712篇 |
药学 | 14502篇 |
56篇 | |
中国医学 | 2909篇 |
肿瘤学 | 2661篇 |
出版年
2024年 | 135篇 |
2023年 | 1061篇 |
2022年 | 1524篇 |
2021年 | 2625篇 |
2020年 | 2849篇 |
2019年 | 2479篇 |
2018年 | 2346篇 |
2017年 | 2551篇 |
2016年 | 2358篇 |
2015年 | 2301篇 |
2014年 | 4986篇 |
2013年 | 6615篇 |
2012年 | 4299篇 |
2011年 | 4567篇 |
2010年 | 3628篇 |
2009年 | 3282篇 |
2008年 | 3120篇 |
2007年 | 2960篇 |
2006年 | 2633篇 |
2005年 | 2205篇 |
2004年 | 1760篇 |
2003年 | 1613篇 |
2002年 | 1327篇 |
2001年 | 1168篇 |
2000年 | 927篇 |
1999年 | 779篇 |
1998年 | 636篇 |
1997年 | 605篇 |
1996年 | 482篇 |
1995年 | 459篇 |
1994年 | 388篇 |
1993年 | 384篇 |
1992年 | 368篇 |
1991年 | 336篇 |
1990年 | 298篇 |
1989年 | 236篇 |
1988年 | 232篇 |
1987年 | 195篇 |
1986年 | 198篇 |
1985年 | 244篇 |
1984年 | 194篇 |
1983年 | 131篇 |
1982年 | 141篇 |
1981年 | 129篇 |
1980年 | 116篇 |
1979年 | 65篇 |
1978年 | 59篇 |
1977年 | 39篇 |
1976年 | 62篇 |
1975年 | 29篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
81.
Elisa Giani Andrea Enzo Scaramuzza Gian Vincenzo Zuccotti 《World journal of diabetes》2015,6(8):999-1004
Technologies for diabetes management, such as continuous subcutaneous insulin infusion (CSII) and continuous glucose monitoring (CGM) systems, have improved remarkably over the last decades. These developments are impacting the capacity to achieve recommended hemoglobin A1c levels and assisting in preventing the development and progression of micro- and macro vascular complications. While improvements in metabolic control and decreases in risk of severe and moderate hypoglycemia have been described with use of these technologies, large epidemiological international studies show that many patients are still unable to meet their glycemic goals, even when these technologies are used. This editorial will review the impact of technology on glycemic control, hypoglycemia and quality of life in children and youth with type 1 diabetes. Technologies reviewed include CSII, CGM systems and sensor-augmented insulin pumps. In addition, the usefulness of advanced functions such as bolus profiles, bolus calculators and threshold-suspend features will be also discussed. Moreover, the current editorial will explore the challenges of using these technologies. Indeed, despite the evidence currently available of the potential benefits of using advanced technologies in diabetes management, many patients still report barriers to using them. Finally this article will highlight the importance of future studies tailored toward overcome these barriers to optimizing glycemic control and avoiding severe hypoglycemia. 相似文献
82.
Fiene Marie Kuijper Uma V. Mahajan Seul Ku Daniel A.N. Barbosa Sheila M. Alessi Sherman C. Stein Kyle M. Kampman Brandon S. Bentzley Casey H. Halpern 《Neuromodulation》2022,25(2):253-262
ObjectivesCocaine is the second most frequently used illicit drug worldwide (after cannabis), and cocaine use disorder (CUD)-related deaths increased globally by 80% from 1990 to 2013. There is yet to be a regulatory-approved treatment. Emerging preclinical evidence indicates that deep brain stimulation (DBS) of the nucleus accumbens may be a therapeutic option. Prior to expanding the costly investigation of DBS for treatment of CUD, it is important to ensure societal cost-effectiveness.AimsWe conducted a threshold and cost-effectiveness analysis to determine the success rate at which DBS would be equivalent to contingency management (CM), recently identified as the most efficacious therapy for treatments of CUDs.Materials and MethodsQuality of life, efficacy, and safety parameters for CM were obtained from previous literature. Costs were calculated from a societal perspective. Our model predicted the utility benefit based on quality-adjusted life-years (QALYs) and incremental-cost-effectiveness ratio resulting from two treatments on a one-, two-, and five-year timeline.ResultsOn a one-year timeline, DBS would need to impart a success rate (ie, cocaine free) of 70% for it to yield the same utility benefit (0.492 QALYs per year) as CM. At no success rate would DBS be more cost-effective (incremental-cost-effectiveness ratio <$50,000) than CM during the first year. Nevertheless, as DBS costs are front loaded, DBS would need to achieve success rates of 74% and 51% for its cost-effectiveness to exceed that of CM over a two- and five-year period, respectively.ConclusionsWe find DBS would not be cost-effective in the short term (one year) but may be cost-effective in longer timelines. Since DBS holds promise to potentially be a cost-effective treatment for CUDs, future randomized controlled trials should be performed to assess its efficacy. 相似文献
83.
84.
85.
Alisson R. Teles Don Daniel Ocay Abdulaziz Bin Shebreen Andrew Tice Neil Saran Jean A. Ouellet Catherine E. Ferland 《The spine journal》2019,19(4):677-686
BACKGROUND CONTEXT
Although 40% of adolescent idiopathic scoliosis (AIS) patients present with chronic back pain, the pathophysiology and underlying pain mechanisms remain poorly understood. We hypothesized that development of chronic pain syndrome in AIS is associated with alterations in pain modulatory mechanisms.PURPOSE
To identify the presence of sensitization in nociceptive pathways and to assess the efficacy of the diffuse noxious inhibitory control in patients with AIS presenting with chronic back pain.STUDY DESIGN
Cross-sectional study.PATIENT SAMPLE
Ninety-four patients diagnosed with AIS and chronic back pain.OUTCOME MEASURES
Quantitative sensory testing (QST) assessed pain modulation and self-reported questionnaires were used to assess pain burden and health-related quality of life.METHODS
Patients underwent a detailed pain assessment using a standard and validated quantitative sensory testing (QST) protocol. The measurements included mechanical detection thresholds (MDT), pain pressure threshold (PPT), heat pain threshold (HPT), heat tolerance threshold (HTT), and a conditioned pain modulation (CPM) paradigm. Altogether, these tests measured changes in regulation of the neurophysiology underlying the nociceptive processes based on the patient's pain perception. Funding was provided by The Louise and Alan Edwards Foundation and The Shriners Hospitals for Children.RESULTS
Efficient pain inhibitory response was observed in 51.1% of patients, while 21.3% and 27.7% had sub-optimal and inefficient CPM, respectively. Temporal summation of pain was observed in 11.7% of patients. Significant correlations were observed between deformity severity and pain pressure thresholds (p=.023) and CPM (p=.017), neuropathic pain scores and pain pressure thresholds (p=.015) and temporal summation of pain (p=.047), and heat temperature threshold and pain intensity (p=.048).CONCLUSIONS
Chronic back pain has an impact in the quality of life of adolescents with idiopathic scoliosis. We demonstrated a high prevalence of impaired pain modulation in this group. The association between deformity severity and somatosensory dysfunction may suggest that spinal deformity can be a trigger for abnormal neuroplastic changes in this population contributing to chronic pain syndrome. 相似文献86.
《The Journal for Nurse Practitioners》2020,16(4):258-261
Prescribing of proton pump inhibitors (PPIs) has markedly increased since their inception more than 30 years ago. The increase is related to inappropriate and long-term prescribing of PPIs, associated with a lack of education and unclear prescribing and deprescribing guidelines. The implementation of prescribing stewardship programs influences the reduction and inappropriate use of this medication. The purpose of this review is to address the gaps that exist regarding the use of PPIs along with determining methods for deprescribing. Guidelines and stewardship programs, along with education, are needed to reduce the adverse health effects of long-term PPI therapy. 相似文献
87.
88.
目的: 研究急性出血坏死性胰腺炎(AHNP)肝损伤中Toll-样受体(TLR)2/4mRNA表达的变化及氯喹的干预效应。 方法:采用逆行胰胆管牛磺胆酸钠(TAC)注射造成大鼠AHNP肝损伤动物模型。动物分为假手术组(S组)、胰腺炎组和氯喹(CQ)治疗组。后2组于术后3,6,12 h分批剖杀,S组于术后6 h剖杀。观察血清淀粉酶、ALT和AST及肝组织NO和TNF-α的变化,RT-PCR方法检测各组不同时点肝组织TLR2和TLR4mRNA的表达。 结果:相对于S组,胰腺炎组大鼠3 h肝组织TLR2和TLR4mRNA表达开始增高,术后6~12 h肝组织TLR2和TLR4mRNA表达迅速达到峰值(P<0.05),肝损伤加重,血清淀粉酶升高,肝组织TNF-α浓度升高,NO浓度逐渐降低(P<0.05);相对胰腺炎组,CQ治疗组TLR2/4mRNA表达降低(P<0.05),肝损伤程度减轻,血清淀粉酶降低,肝组织TNF-α浓度降低,NO浓度显著升高(P<0.05)。 结论:AHNP大鼠肝组织内TLR2和TLR4的基因表达上调;其表达增高可能在AHNP肝损伤的发生、发展中起重要作用。氯喹对大鼠AHNP过程中肝损伤可能有保护作用。 相似文献
89.
根据医学摄影不同拍摄对象,结合各种光源特点,介绍了用光的一般方法和掌握的基本原则,对物体的反光控制、透明物体内部结构与质感的表现等难点问题进行了研讨,并对荧光摄影作了简要介绍。 相似文献
90.